Plain-English translation of NCT06861582 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to measure troponin—a protein that rises in your blood when your heart is damaged—using a quick fingertip blood test done right in the emergency room. The study compares this fast test to the traditional laboratory method to see which one helps doctors diagnose heart problems more quickly and safely.
Heart attacks are life-threatening emergencies, and the faster doctors can diagnose them, the better the chance of survival and recovery. This study aims to find out whether a quicker blood test method can speed up diagnosis and get patients discharged or treated sooner.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the new quick fingertip blood test or the standard laboratory blood test. Either way, you'll have blood samples taken when you arrive at the emergency room and again one hour later. The study simply tracks how long you stay in the hospital—you won't need extra visits or tests beyond what doctors already plan to do to diagnose your chest pain.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Brazil
Sponsor
University of Sao Paulo
Enrollment target
~200 participants
Started
March 2025
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
José León
University of Sao Paulo
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.